NCT05815784View on ClinicalTrials.gov

Myopia Control: a Comparison Study Between Atropine and MiSight

PHASE2RecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

March 13, 2026

Study Completion Date

March 13, 2026

Conditions
Myopia
Interventions
DRUG

Atropine

0.05% atropine. One drop per eye per day for 2 years.

DEVICE

MiSight contact lenses

Daily wear for 2 years.

Trial Locations (1)

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER